FPN || Rheumatology

In psoriasis, is pushing for PASI 90 really worthwhile?

Posted on: 19/10/2014 - 15:40

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Dermatology
Type: News Item

Biosimilars poised to make biologics more routine

Posted on: 16/10/2014 - 13:00

The biosimilar age for rheumatology has arrived, and experts expect wider use of previously expensive biologic drugs as biosimilar competition drives prices down and makes biologics more...

Field of Interest: Rheumatology
Type: News Item

Drug combos for psoriatic arthritis upped shingles risk

Posted on: 10/10/2014 - 13:56

Combining tumor necrosis factor-alpha inhibitors with conventional disease-modifying antirheumatic drugs more than doubled the risk of shingles in patients with psoriatic arthritis, according to a...

Field of Interest: Rheumatology
Type: News Item

Drug combos for psoriatic arthritis upped shingles risk

Posted on: 10/10/2014 - 13:56

Combining tumor necrosis factor-alpha inhibitors with conventional disease-modifying antirheumatic drugs more than doubled the risk of shingles in patients with psoriatic arthritis, according to a...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More